Company stock · NYSE · USD

BSX

Boston Scientific Corp

—

Price unavailable — company details still show below

Sector: Healthcare
Industry: Health Care
Size: Large company
Market value: $66.2 billion
Number of shares: 1.45 billion
Country: US
Went public: May 19, 1992
Exchange: NYSE
Website: bostonscientific.com
Next earnings: 2026-10-28 · Before open · analysts’ expected profit per share $0.74

Compare →Earnings calendar →

Price chart Pro

Loading chart…

Company briefing

What BSX is

Plain English context — why the name shows up in the news, and what to watch next.

In plain English

Boston Scientific Corp. designs and sells medical devices, including pacemakers and neuromodulation equipment, to hospitals and clinicians…

Recent headlines

Live company news for BSX — each headline includes a ClearTape brief in plain English; open the original for the full story.

Pacemakers Market Forecasts Growth from $5.4 Billion (2025) to $7.5 Billion by 2030, Profiling Medtronic, Abbott, Boston Scientific, Biotronik & 6 Other Key PlayersIn brief
108-Page Report Examines the Shift to Leadless and MRI-Compatible Devices as Rising Arrhythmia Prevalence Drives Demand, While High Procedure Costs, Strict Approvals and Cybersecurity Risks Weigh on GrowthDublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "Pacemakers: Global Markets" has been added to ResearchAndMarkets.com's offering.
Yahoo · Oct 23, 2026
Insights Into Boston Scientific (BSX) Q3: Wall Street Projections for Key MetricsIn brief
The article reviews Wall Street’s earnings estimates for Boston Scientific’s Q3, focusing on key metrics to understand the company’s performance in the quarter ending September 2026.
Yahoo · Oct 23, 2026
Boston Scientific (BSX) Stock May Be 44% Undervalued As Neuromodulation Growth BuildsIn brief
Boston Scientific’s share price has dropped 57.1% over the past year, raising questions about whether the current valuation reflects its expected cash flow, especially as the company expands into neuromodulation devices.
Yahoo · Oct 22, 2026
Australia Bionic Devices Market Size, Share, Growth, and Forecast 2026-2034 Featuring Profiles of Cochlear, Medtronic Australasia, Edwards Lifesciences Australia, Baxter Int'l, Boston Scientific Corp., Abiomed Australia, Abbott LabsIn brief
Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Australia Bionic Devices Market Report by Product, Fixation, Technology, End User, States and Companies Analysis 2026-2034" has been added to ResearchAndMarkets.com's offering.
Yahoo · Oct 22, 2026
Can Boston Scientific Stock Jump 30%?In brief
The piece asks whether Boston Scientific’s stock could rise 30%.
Yahoo · Oct 22, 2026
Can Boston Scientific Stock Bounce Off This Support Again?In brief
The article questions if Boston Scientific’s stock can rebound off a particular support level.
Yahoo · Oct 22, 2026
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for InvestorsIn brief
Boston Scientific closed at $44.51, down 2.35% from the previous day, while the broader market improved.
Yahoo · Oct 21, 2026
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings GrowthIn brief
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · Oct 21, 2026

Same sector

Similar companies · Healthcare

% is today vs yesterday’s close

Latest on this name

Insights & deeper context

Cards about this company show up here when there is news.

No insights yet

Search another name, add BSX to your watchlist, or check back when fresh news hits. If this company also trades in the US, the “Same company” link above opens that listing.

Back to feed →

Company reports

Official filings (US SEC and linked cards)

No filings here yet

Official report cards for BSX will show up here when available.

Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.